9th U.S. Circuit Court of Appeals
Jul. 10, 2017
Gilead must face allegations of circumventing FDA regulations, court rules
The 9th U.S. Circuit Court of Appeals on Friday revived a whistleblower case against Gilead Sciences Inc. in which former employees accuse the company of using unapproved ingredients in HIV medications supported by government funding.
The 9th U.S. Circuit Court of Appeals has revived a whistleblower case against Gilead Sciences Inc. in which former employees accuse the company of using unapproved ingredients in HIV medications supported by government funding.
The plaintiffs claim they were discriminated against for confronting the company’s leadership over alleged violations of the False Claims Act.
The former employees say in th...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In